Rallybio Holds Annual Shareholder Meeting
Bitget2026/11/04 22:55- Rallybio shareholders approved share issuance for the proposed Avenzo merger at the November 4, 2026, annual meeting.
- Shareholders authorized a 1-for-2 to 1-for-9 reverse stock split and an increase in authorized common shares from 200,000,000 to 500,000,000.
- They also approved renaming the company Avenzo Therapeutics and elected four Class II directors.
- The 2026 Equity Incentive Plan and Employee Stock Purchase Plan won approval, with effectiveness contingent on merger completion.
- Shareholders ratified Deloitte & Touche as auditor for fiscal 2026; the proposed adjournment was unnecessary and not submitted for approval.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Microsoft Beats Nvidia for the First Time Since 2025: So Why Is MSFT Stock Falling?
Gunnison hits rich copper and zinc in Arizona
EIA expects Brent crude spot prices to remain at $100 per barrel for the rest of the year and raises the average price forecasts for this year and next.
The U.S. Energy Information Administration (EIA) has raised its forecast for average Brent crude oil prices in 2026 and 2027 to $97 and $86, respectively, reflecting pressures from global inventory declines, Middle East supply disruptions, and rising transportation costs. As oil production in the Middle East gradually recovers and global inventories rebound from low levels, the EIA expects the average spot price of Brent crude to fall to $87 per barrel in the second quarter of 2027, and further decline to $77 per barrel by the fourth quarter.
Crypto prices
More
